Table 2.
Control group (n = 15) |
Intervention group (n = 13) |
Δa | P b | |||||
---|---|---|---|---|---|---|---|---|
Baseline | 6 months | Change | Baseline | 6 months | Change | |||
MPR %, mean ± SD | 92.7 ± 6.8 | 91.7 ± 8.6 | −1.1 ± 6.0 | 89.1 ± 9.8 | 91.8 ± 8.9 | 2.7 ± 6.7 | 3.8 | .13 |
Cap adherence %, mean ± SD | 55.1 ± 27.3 | 65.0 ± 28.0 | 9.9 ± 22.5 | 60.7 ± 33.0 | 72.6 ± 28.3 | 11.9 ± 26.8 | 2.0 | .83 |
MMAS-8 score, mean ± SD | 5.7 ± 1.3 | 6.5 ± 1.5 | 0.8 ± 1.3 | 6.2 ± 1.1 | 7.2 ± 1.1 | 1.1 ± 1.4 | 0.3 | .64 |
Abbreviation: MPR, medication possession ratio; MMAS, morisky medication adherence scale.
Refers to the difference between the change from baseline to 6 months in the control and intervention groups.
Refers to the comparison of change from baseline to 6 months between the control and intervention groups using an independent samples t test.